참고문헌
- Al-Sarraf M (1988). Head and neck cancer: chemotherapy concepts. Semin Oncol, 15, 70-85.
- Baykara M, Buyukberber S, Ozturk B, et al (2013). Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers. Asian Pac J Cancer Prev, 14, 2557-61. https://doi.org/10.7314/APJCP.2013.14.4.2557
- Bertino G, Occhini A, Falco CE, et al (2009).Concurrent intraarterial carboplatin administration and radiation therapy for treatment of advanced head and neck squamous cell carcinoma: short term results. BMC Cancer, 9, 313. https://doi.org/10.1186/1471-2407-9-313
- Calais G, Alfonsi M, Bardet E, et al (1999). Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst, 91, 2081-6. https://doi.org/10.1093/jnci/91.24.2081
- Calcattera TC, Juillard GJ (1995). Oral cavity and hypopharynxhead and neck cancer. In: Haskell CM, Berek JS, editors. Cancer Treatment. WB Saunders Co:Philadelphia, .p.726-732.
- Denis F, Garaud P, Bardet E, et al (2004). Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced stage oropharynx carcinoma. J Clin Oncol, 22, 69-76.
- Dinshaw KA, Rao DN, Ganesh B (2000). Hospital based cancer registry, annual report, Tata Memorial Hospital, Mumbai, India.
- Eisenberger M, Sinibaldi V, Jacobs M, Gray W (1988). Simultaneous treatment with carboplatin (NSC-241-240) and radiotherapy in advanced unresectable squamous cell carcinomas of the head and neck. Cancer Treat Rev, 1988, 3-7.
- Haddad R, O'Neill A, Rabinowits G, et al (2013). Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol, 14, 257-64. https://doi.org/10.1016/S1470-2045(13)70011-1
- Herman LC, Chen L, Garnett A, et al (2014). Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer. Oral Oncol, 50, 52-8. https://doi.org/10.1016/j.oraloncology.2013.08.007
- Hosokawa Y, Kamada T, Shirato H, et al (1995). Simultaneous carboplatin and radiotherapy for all stages of head and neck squamous cell carcinoma. Clin Oncol, 7, 168-72. https://doi.org/10.1016/S0936-6555(05)80510-2
- Mabanta SR, Mendenhall WM, Stringer SP, Cassisi NJ (1999). Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinomawith clinically positive neck nodes. Head Neck, 21, 591-4 https://doi.org/10.1002/(SICI)1097-0347(199910)21:7<591::AID-HED1>3.0.CO;2-Y
- Nam EJ, Lee M, Yim GA, et al (2013). Comparison of carboplatinand cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks. Oncologist, 18, 843-9. https://doi.org/10.1634/theoncologist.2012-0455
- Nguyen NP, Vos P, Smith HJ, et al (2007). Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol, 28, 3-8. https://doi.org/10.1016/j.amjoto.2006.03.007
- Okami K, Hamano T, Takeo T, Sugimoto R, Sekine M (2007). A survey of head and neck malignancy at Tokai University Hospital. Tokai J Exp Clin Med, 32, 62-6.
- Pignon JP, Bourhis J, Domenge C, Designe L (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta. analyses of updated individual data. Lancet, 355, 949-55. https://doi.org/10.1016/S0140-6736(00)90011-4
- Robert JK, Benjamin GW, Cleveland OH, et al (1988). Squamous cell carcinoma of head and neck in patients 40 years of age and younger. Laryngocsope, 531-3.
- Seiwert TY, Salama JK, Vokes EE (2007). The concurrent chemoradiation paradigm-general principles. Nat Clin Pract Oncol, 4, 86-100. https://doi.org/10.1038/ncponc0714
- Shah JP, Ladd W (1995). Treatment of cancer of the head and neck. CA Cancer J Clin, 45, 352-68. https://doi.org/10.3322/canjclin.45.6.352
- Taguchi T, Tsukuda M, Mikami Y, et al (2009). Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Auris Nasus Larynx, 36, 199-204. https://doi.org/10.1016/j.anl.2008.04.003
- Takiar R, Nadayil d, Nandakumar A (2010). Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev, 11, 1045-9.
- Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993). Head and neck cancer. N Engl J Med, 328, 184-94. https://doi.org/10.1056/NEJM199301213280306
- Yang LX, Douple E, Wang HJ (1995). Irradiation- enhanced binding of carboplatin to DNA. Int J Radiat Biol, 68, 609-614. https://doi.org/10.1080/09553009514551611
- Zhu WG, Zhou K, Yu CH, et al (2012). Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma.. Asian Pac J Cancer Prev, 13, 803-7. https://doi.org/10.7314/APJCP.2012.13.3.803
피인용 문헌
- Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6227
- DOX-MTX-NPs Augment p53 mRNA Expression in OSCC Model in Rat: Effects of IV and Oral Routes vol.15, pp.19, 2014, https://doi.org/10.7314/APJCP.2014.15.19.8377
- New formulated "DOX-MTX-loaded Nanoparticles" Down-regulate HER2 Gene Expression and Improve the Clinical Outcome in OSCCs Model in Rat: the Effect of IV and Oral Modalities vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9355
- Competing Causes of Death in 138 Patients with Loco-Regionally Advanced Head and Neck Cancer Treated with Multi-Modality Treatment vol.06, pp.05, 2015, https://doi.org/10.4236/jct.2015.65045
- Educational Levels and Delays in Start of Treatment for Head and Neck Cancers in North-East India vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10867
- Radiotherapy and Concurrent Chemo-Radiotherapy in Locally Advanced Hypopharyngeal Cancers - A Hospital Registry Based Analysis vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4723
- Weekly Cisplatin-Based Concurrent Chemoradiotherapy for Treatment of Locally Advanced Head and Neck Cancer: a Single Institution Study vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7309
- Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7331
- Survival in Head and Neck Cancers - Results of A Multi-Institution Study vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1745